PEPTIDVERBINDUNG

European patent · EP3467106 · In force

Register entry

Publication number
EP3467106
Application number
EP17802805
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 23, 2017
Published
Apr 10, 2019
Granted
Jul 9, 2025
Protection ends at the latest
May 22, 2037
Next annual fee due
May 31, 2026
IPC classes
C12N 15/09 (2006.01)
A61K 38/16 (2006.01)
A61P 3/10 (2006.01)
C07K 14/575 (2006.01)
Priority
JP 2016103011 24.05.2016
PCT application
PCT/JP2017/019220 23.05.2017
PCT publication
WO2017/204219 30.11.2017
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 21, 2026

    Change

    Published in Swissreg on 21.05.2026

  2. Jul 9, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.07.2025

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045, JP

Inventor

ASAMI, Taiji

Fujisawa-shi Kanagawa 251-0012, JP

NIIDA, Ayumu

Fujisawa-shi Kanagawa 251-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.